glp-1 parkinson's disease lancet The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in disease: mechanisms of action Beyond a singular focus on

The Importance of Medical Supervision and Prescribed Dosing Following prescribed dosages is vital for patients using GLP-1 receptor agonists

Significantly so

GLP-1 receptor agonists are extensively used in treating diabetes and obesity, yet little is known about the long-term ocular effects of systemic prolonged exposure, wrote lead investigator Reut Shor, M.D., a researcher in the department of Ophthalmology and Vision Sciences at the University of Toronto

21 Bariatric surgery In a retrospective analysis of 2,695 patients who underwent bariatric surgery, 1.04% of patients (versus 0.017% of the general population) developed acute pancreatitis during a median follow-up of 3.5 years (interquartile range 1.95.8 years)